![Thomas Gad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Thomas Gad is the founder of Singad Pharma Aps, founded in 2003.
Mr. Gad was the founder of Y-mAbs Therapeutics, Inc., founded in 2015, holding the title of Vice Chairman & Chief Business Officer from 2023 to 2025.
Education includes an undergraduate degree from Pepperdine University.
Precedenti posizioni note di Thomas Gad
| Società | Posizione | Fine |
|---|---|---|
| YMAS THER | Amministratore Delegato | 06/11/2023 |
Singad Pharma Aps | Fondatore | 01/01/2013 |
Formazione di Thomas Gad
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
8
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singad Pharma Aps | |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
